| TCGA | The Cancer Genome Atlas |
| POLE | DNA polymerase epsilon |
| MSI | microsatellite instability |
| ESGO/ESTRO/ESP | European Society of Gynaecological Oncology, European SocieTy for Radiotherapy and Oncology, European Society of Pathology |
| USA | United States of America |
| EEC | endometrial endometrioid carcinoma |
| SEC | serous endometrial carcinoma |
| CCEC | clear cell endometrial carcinoma |
| UEC/DEC | Undifferentiated/dedifferentiated endometrial carcinoma |
| UCS | uterine carcinosarcoma |
| NEEC | neuroendocrine endometrial carcinoma |
| MLEC | mesonephric-like endometrial carcinoma |
| GTEC | gastric/gastrointestinal-type endometrial carcinoma |
| LVSI | lymphovascular space invasion |
| FIGO | International Federation of Gynecology and Obstetrics |
| DNA | Deoxyribonucleic Acid |
| SCNA | somatic copy-number alteration |
| MMR | mismatch repair |
| MMRd | MMR-deficient |
| p53abn | p53-abnormal |
| NSMP | no specific molecular profile |
| AEH/EIN | atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia |
| MELF | microcystic, elongated, and fragmented |
| NCCN | National Comprehensive Cancer Network |
| TCs | Tumor cells |
| ICs | immune cells |
| CPS | combined positive score |